Accelerating Discovery Covid Vaccine Breakthroughs

Accelerating Discovery: COVID-19 Vaccine Breakthroughs and their Future Impact

While some vaccines can take almost 15 years to be approved, the rate at which COVID-19 vaccines have been developed (1 year) is truly remarkable. The collaboration across disciplines, continents, and companies was unheard of and several emerging technologies emerged as key players.  From mRNA to lipid nanoparticles to cross protection of vaccines – this vaccine rush has re-shaped the landscape ahead.

Accelerating Covid Vaccine Breakthroughs white paper cover image

Download the CAS insights report

Related CAS Insights

Highlights from the CAS Insights webinar on the pharmaceutical patent landscape

White immune cells attacking a large pink cancer cell on a red tissue surface.

New translational research in immuno-oncology may reach patients who do not respond to current therapies

Pharmaceutical capsule containing a glowing orange DNA helix on a dark circuit board background.

CAS Insights Report: Unlocking the future of pharmaceutical innovation through patent intelligence.

Gain new perspectives for faster progress directly to your inbox.